We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

By LabMedica International staff writers
Posted on 09 Feb 2026

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership, with a particular focus on the impact of AI and automation.

The session, titled “Transformational Leadership – Creating Next Gen Laboratory Leaders”, will take place on Tuesday, 10 February, as part of the Laboratory Management track within the event’s Laboratory Management and Medicine Congress.

Bringing together regional and international experts, speakers include Dr. More...

Laila AbdelWareth, CEO, Diagnostics Global Patient Care, M42; Mark O'Brien, Associate Fellow and Programme Director, Oxford Healthcare Leadership Programme, Saïd Business School, Oxford University; Ziad Peerwani, Medical Director, Cleveland Clinic Reference Laboratory; Shweta Narang, Executive Director – Medical & Commercial Operations, Diagnostics, Global Patient Care, M42; and Rubina Lone, Consultant Pathologist, Dubai Health.

Speaking ahead of the session, Dr AbdelWareth said: “Transformational leaders are those who inspire others to achieve extraordinary outcomes and, in the process, develop their own leadership capacity. In the context of AI and automation, they are the laboratory leaders that anticipate emerging technologies, design future workflows and strategically steer laboratories into digital maturity.”

She added that leaders must be equipped not only to deliver operational improvements, but to take responsibility for safe, ethical adoption of AI across diagnostics and patient pathways. “Leaders must apply ethical judgement, implement safeguards, and ensure compliance with accreditation, validation, and safety standards as AI introduces new liabilities — model errors, bias, drift and more,” she said.  

The session will also examine how laboratory roles and career pathways should evolve as AI takes on a growing share of routine and analytical tasks. Dr. AbdelWareth explained: “AI is not simply adding tools to our workflow; it is reshaping the skills architecture of the entire profession. Career pathways must evolve from traditional, linear ladders to dynamic, multi-track growth routes that align with digital diagnostics, advanced analytics and quality-driven oversight.”

She noted that future-focused laboratory teams will increasingly include emerging roles such as AI-augmented laboratory professionals, AI algorithm supervisors, laboratory informatics liaisons, and automation and workflow architects, with AI literacy becoming a baseline requirement for all laboratory professionals.

Looking ahead, Dr. AbdelWareth said leadership skillsets are shifting from traditional management to strategic and human-centric capabilities that support high-performing teams through uncertainty, with the next generation of laboratory leaders defined not by how well they manage routine processes, but by how effectively they harness, govern, and ethically oversee AI-driven diagnostic environments.

Tom Coleman, Portfolio Director, Informa Markets, said: “Laboratories are entering a new era where technologies such as AI and automation are accelerating progress across diagnostics, quality and operational performance. This session will provide practical insights into how the industry must adapt to ensure laboratories can harness innovation safely, ethically and effectively.”

The region’s leading laboratory and diagnostics event, WHX Labs in Dubai will bring together the global laboratory community to discover cutting-edge diagnostics, technology and innovation. The event is held under the patronage of the UAE Ministry of Health and Prevention, reinforcing the nation’s commitment to delivering world-leading healthcare.

WHX Labs in Dubai is co-timed with World Health Expo (WHX) in Dubai, held at Dubai Exhibition Centre (DEC) from 9-12 February, reinforcing Dubai’s role as a global hub for healthcare innovation. Together, the two events are set to welcome over 270,000 healthcare professionals and 4,800 exhibitors from more than 180 countries.

Marking a quarter of a century of success, WHX Labs in Dubai will be held under the theme “25 years of laboratory innovation: Uniting Communities for better health” and will present an international showcase of excellence in laboratories, diagnostics and precision medicine.

WHX Labs in Dubai coincides with World Health Expo (WHX) in Dubai, which will be held from 9-12 February at Dubai Exhibition Centre.

Related Links:
WHX Labs Dubai


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.